Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol 4,5-bisphosphate (PIP2) is a minor but functionally critical phospholipid component of eukaryotic cell membranes that serves as a key signaling scaffold and a precursor to several intracellular second messengers (Balla, 2013). It is cleaved by phospholipase C to generate inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), and phosphorylated by PI3K to produce PIP3, all of which are vital for signal transduction (Di Paolo & De Camilli, 2006). Beyond its role as a precursor, PIP2 directly regulates the activity of numerous ion channels, transporters, and proteins involved in actin cytoskeleton remodeling and vesicular trafficking (McLaughlin et al., 2002). Dysregulation of phosphoinositide metabolism is a central feature in many human pathologies, including cancer, where the PI3K/AKT/mTOR pathway is frequently hyperactivated, and various genetic disorders like Lowe syndrome (Suh & Hille, 2008). Therapeutic strategies include the use of small molecules that sequester these lipids, such as certain aminoglycosides, or more commonly, inhibitors of the kinases and phosphatases that regulate their interconversion (Gabev et al., 1989). Because phosphoinositides are fundamental to basic cellular homeostasis across all tissues, targeting them directly presents significant challenges regarding the therapeutic index and potential for systemic toxicity (Balla, 2013).
Direct binding and sequestration of phosphoinositides, inhibition of downstream signaling cascades by blocking lipid-protein interactions, or modulation of membrane lipid composition.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol 4,5-bisphosphate (PIP2) (PIP2).